These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


533 related items for PubMed ID: 31877991

  • 21. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N, Damodaran TV, Winn MP.
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [Abstract] [Full Text] [Related]

  • 22. Tyrosine phosphorylation-dependent activation of TRPC6 regulated by PLC-γ1 and nephrin: effect of mutations associated with focal segmental glomerulosclerosis.
    Kanda S, Harita Y, Shibagaki Y, Sekine T, Igarashi T, Inoue T, Hattori S.
    Mol Biol Cell; 2011 Jun 01; 22(11):1824-35. PubMed ID: 21471003
    [Abstract] [Full Text] [Related]

  • 23. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
    Chiluiza D, Krishna S, Schumacher VA, Schlöndorff J.
    J Biol Chem; 2013 Jun 21; 288(25):18407-20. PubMed ID: 23645677
    [Abstract] [Full Text] [Related]

  • 24. Cryo-EM structure of the cytoplasmic domain of murine transient receptor potential cation channel subfamily C member 6 (TRPC6).
    Azumaya CM, Sierra-Valdez F, Cordero-Morales JF, Nakagawa T.
    J Biol Chem; 2018 Jun 29; 293(26):10381-10391. PubMed ID: 29752403
    [Abstract] [Full Text] [Related]

  • 25. TRPC6 in glomerular health and disease: what we know and what we believe.
    Schlöndorff JS, Pollak MR.
    Semin Cell Dev Biol; 2006 Dec 29; 17(6):667-74. PubMed ID: 17116414
    [Abstract] [Full Text] [Related]

  • 26. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P, Canales CP, Kairath P, Carmona-Mora P, Molina J, Carpio JD, Ruiz P, Mezzano SA, Li J, Wei C, Reiser J, Young JI, Walz K.
    PLoS One; 2010 Sep 20; 5(9):e12859. PubMed ID: 20877463
    [Abstract] [Full Text] [Related]

  • 27. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease.
    Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, Pippin JW, Rastaldi MP, Wawersik S, Schiavi S, Henger A, Kretzler M, Shankland SJ, Reiser J.
    J Am Soc Nephrol; 2007 Jan 20; 18(1):29-36. PubMed ID: 17167110
    [Abstract] [Full Text] [Related]

  • 28. Balancing calcium signals through TRPC5 and TRPC6 in podocytes.
    Greka A, Mundel P.
    J Am Soc Nephrol; 2011 Nov 20; 22(11):1969-80. PubMed ID: 21980113
    [Abstract] [Full Text] [Related]

  • 29. A Putative Role for TRPC6 in Immune-Mediated Kidney Injury.
    't Hart DC, van der Vlag J, Nijenhuis T.
    Int J Mol Sci; 2023 Nov 16; 24(22):. PubMed ID: 38003608
    [Abstract] [Full Text] [Related]

  • 30. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.
    Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR.
    Nat Genet; 2005 Jul 16; 37(7):739-44. PubMed ID: 15924139
    [Abstract] [Full Text] [Related]

  • 31. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
    Yu M, Hu J, Ju T, Wang R, Wang M, Gao C, Xia Z.
    Cell Mol Biol (Noisy-le-grand); 2024 May 27; 70(5):284-288. PubMed ID: 38814201
    [Abstract] [Full Text] [Related]

  • 32. The roles of TRPC6 in renal tubular disorders: a narrative review.
    Sheng A, Liu F, Wang Q, Fu H, Mao J.
    Ren Fail; 2024 Dec 27; 46(2):2376929. PubMed ID: 39022902
    [Abstract] [Full Text] [Related]

  • 33. TRPC6 G757D Loss-of-Function Mutation Associates with FSGS.
    Riehle M, Büscher AK, Gohlke BO, Kaßmann M, Kolatsi-Joannou M, Bräsen JH, Nagel M, Becker JU, Winyard P, Hoyer PF, Preissner R, Krautwurst D, Gollasch M, Weber S, Harteneck C.
    J Am Soc Nephrol; 2016 Sep 27; 27(9):2771-83. PubMed ID: 26892346
    [Abstract] [Full Text] [Related]

  • 34. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
    Kim EY, Roshanravan H, Dryer SE.
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep 27; 1863(9):2342-2354. PubMed ID: 28629718
    [Abstract] [Full Text] [Related]

  • 35. Role of TRPC3 and TRPC6 channels in the myocardial response to stretch: Linking physiology and pathophysiology.
    Yamaguchi Y, Iribe G, Nishida M, Naruse K.
    Prog Biophys Mol Biol; 2017 Nov 27; 130(Pt B):264-272. PubMed ID: 28645743
    [Abstract] [Full Text] [Related]

  • 36. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
    Schlöndorff J, Del Camino D, Carrasquillo R, Lacey V, Pollak MR.
    Am J Physiol Cell Physiol; 2009 Mar 27; 296(3):C558-69. PubMed ID: 19129465
    [Abstract] [Full Text] [Related]

  • 37. Effects of TRPC6 Inactivation on Glomerulosclerosis and Renal Fibrosis in Aging Rats.
    Kim EY, Dryer SE.
    Cells; 2021 Apr 09; 10(4):. PubMed ID: 33918778
    [Abstract] [Full Text] [Related]

  • 38. Genetic Interactions Between TRPC6 and NPHS1 Variants Affect Posttransplant Risk of Recurrent Focal Segmental Glomerulosclerosis.
    Sun ZJ, Ng KH, Liao P, Zhang Y, Ng JL, Liu ID, Tan PH, Chong SS, Chan YH, Liu J, Davila S, Heng CK, Jordan SC, Soong TW, Yap HK.
    Am J Transplant; 2015 Dec 09; 15(12):3229-38. PubMed ID: 26147534
    [Abstract] [Full Text] [Related]

  • 39. Transient Receptor Potential Canonical 6 (TRPC6) Channel in the Pathogenesis of Diseases: A Jack of Many Trades.
    Saqib U, Munjuluri S, Sarkar S, Biswas S, Mukherjee O, Satsangi H, Baig MS, Obukhov AG, Hajela K.
    Inflammation; 2023 Aug 09; 46(4):1144-1160. PubMed ID: 37072606
    [Abstract] [Full Text] [Related]

  • 40. TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats.
    Kim EY, Dryer SE.
    Cells; 2022 Jun 21; 11(13):. PubMed ID: 35805070
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 27.